Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity.
ACCPAs
Autoimmunity
Citrullinated antigens
Cytokines
Periodontitis
Porphyromonas gingivalis
Rheumatoid arthritis
Rheumatoid factors
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
01
01
2023
revised:
08
02
2023
accepted:
22
02
2023
medline:
27
4
2023
pubmed:
26
4
2023
entrez:
26
4
2023
Statut:
ppublish
Résumé
In RA patients' synovial sites, citrullinated RA-related antigens such as type II collagens, fibrin (ogen), vimentin, and α-enolase could be targeted by ACCPAs. Since ACCPA production can be initiated a long time before RA sign appearance, primary auto-immunization against these citrullinated proteins can be originated from extra-articular sites. It has been shown that there is a significant association between P. gingivalis periodontitis, anti- P. gingivalis antibodies, and RA. P. gingivalis gingipains (Rgp, Kgp) can degrade proteins such as fibrin and α-enolase into some peptides in the form of Arg in the C-terminal which is converted to citrulline by PPAD. Also, PPAD can citrullinate type II collagen and vimentins (SA antigen). P. gingivalis induces inflammation and chemoattraction of immune cells such as neutrophils and macrophages through the increase of C5a (gingipain C5 convertase-like activity) and SCFA secretion. Besides, this microorganism stimulates anoikis, a special type of apoptosis, and NETosis, an antimicrobial form of neutrophil death, leading to the release of PAD1-4, α-enolase, and vimentin from apoptotic cells into the periodontal site. In addition, gingipains can degrade macrophages CD14 and decrease their ability in apoptotic cell removal. Gingipains also can cleave IgGs in the Fc region and transform them into rheumatoid factor (RF) antigens. In the present study, the effects of P. gingivalis on rheumatoid arthritis autoimmune response have been reviewed, which could attract practical insight both in bench and clinic.
Identifiants
pubmed: 37098654
pii: S1567-5769(23)00256-4
doi: 10.1016/j.intimp.2023.109936
pii:
doi:
Substances chimiques
Protein-Arginine Deiminases
EC 3.5.3.15
Vimentin
0
Gingipain Cysteine Endopeptidases
0
Phosphopyruvate Hydratase
EC 4.2.1.11
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
109936Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.